Tectonic Therapeutic To Present on December 3rd, 2024 at the Piper Sandler Healthcare Conference

Rhea-AI Summary

Tectonic Therapeutic (NASDAQ: TECX), a clinical stage biotech company specializing in G-protein coupled receptors (GPCRs), has announced its participation in the Piper Sandler 36th Annual Healthcare Conference. The event will take place in New York from December 3-5, 2024. Alise Reicin, MD, President and CEO, will deliver a presentation on Tuesday, December 3rd, 2024, at 12:30 PM ET.

The presentation will include one-on-one meetings and will be accessible via webcast. Interested parties can access the live webcast through the Investors section of Tectonic's website, where a replay will remain available for approximately 90 days after the conference.

WATERTOWN, Mass., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc. (NASDAQ: TECX) (Tectonic), a clinical stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-protein coupled receptors (GPCRs), today announced that Alise Reicin, MD, President and Chief Executive Officer, will present at the Piper Sandler 36^th Annual Healthcare Conference being held in New York on December 3-5, 2024.

Piper Sandler 36th Annual Healthcare Conference details:
Meetings:	Presentation and one-on-one meetings
Presentation Date:	Tuesday, December 3rd, 2024
Presentation Time:	12:30 PM ET
Presenter:	Alise Reicin, MD, President and Chief Executive Officer
Webcast:	Link

For more information regarding one-on-one meetings, please contact your Piper Sandler representative.

The live webcast can also be accessed under “Events & Presentations” on the Investors section of the Tectonic website at www.tectonictx.com. Once the conference has concluded, a replay of the webcast will be available on the Company’s website for approximately 90 days.

About Tectonic

Tectonic is a clinical-stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-protein coupled receptors (GPCRs). Leveraging its proprietary GEODe™ (GPCRs Engineered for Optimal Discovery) technology platform, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery and harness the human body to modify the course of disease. Tectonic focuses on areas of significant unmet medical need, often where therapeutic options are poor or nonexistent, as these are areas where new medicines have the potential to improve patient quality of life. Tectonic is headquartered in Watertown, Massachusetts. For more information, please visit www.tectonictx.com and follow on LinkedIn.

FAQ

When will Tectonic Therapeutic (TECX) present at the Piper Sandler Healthcare Conference?

Tectonic Therapeutic will present on Tuesday, December 3rd, 2024, at 12:30 PM ET at the Piper Sandler Healthcare Conference in New York.

How can investors access Tectonic Therapeutic's (TECX) Piper Sandler Conference presentation?

Investors can access the live webcast through the 'Events & Presentations' section of Tectonic's website (www.tectonictx.com). A replay will be available for approximately 90 days after the conference.

What is the focus of Tectonic Therapeutic's (TECX) research and development?

Tectonic Therapeutic focuses on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-protein coupled receptors (GPCRs).